STRESS AND PATHOGENESIS OF MAJOR DEPRESSIVE DISORDER. A NARRATIVE REVIEW

被引:0
|
作者
Mangalagiu, Andrei Gabriel [1 ,2 ]
Riga, Sorin [3 ,4 ]
Vasiliu, Octavian [5 ]
Petrescu, Bogdan Mircea [1 ,2 ]
机构
[1] Carol Davila Cent Mil Emergency Univ Hosp, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm Bucharest, Bucharest, Romania
[3] Acad Romanian Scientists, Bucharest, Romania
[4] Prof Dr Alexandru Obregia Clin Hosp Psychiat, Dept Stress Res & Prophylaxis, Bucharest, Romania
[5] Carol Davila Cent Mil Emergency Univ Hosp, Psychiat Dept, Bucharest, Romania
关键词
stress; oxidative stress; major depressive disorder; corticotropin releasing hormone; amygdala; hypotalamo-hypophyseal-adrenal axis; brain-derived neurotrophic factor; glutamate; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; NMDA RECEPTOR; AMYGDALA; BRAIN; HIPPOCAMPAL; CONNECTIVITY; MORPHOLOGY; PATHWAYS;
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The link between Major Depressive Disorder (MDD) and stress was extensively studied in the past decades. The aim of this paper is to attempt at connecting the effects of stress and the pathogenesis of MDD by reviewing the latest data found in literature regarding the evolution of the stress concept, action of stressors on the most involved in stress process brain areas, and the pathogenic theories of depression. Three main conclusions are drawn, namely: 1. the possibility that, under the current diagnostic criteria of MDD, several diseases with different physiopathological but common clinical presentation are hidden; 2. the importance of early detection and prevention of disorder - in the light of data that supports the degenerative and progressive nature of major depression; 3. study of the role of stress in the pathogenesis of depression raises new possibilities in terms of psychosocial interventions, as well as the delimitation of the vulnerable populations to major depressive disorder.
引用
收藏
页码:24 / 35
页数:12
相关论文
共 50 条
  • [31] Meta-analysis of the efficacy of escitalopram and citalopram in the treatment of major depressive disorder.
    Kasper, S
    Auquier, P
    Robitail, S
    Llorca, PM
    Rive, B
    NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 413 - 413
  • [32] Antidepressant for major depressive disorder. Comparison with vortioxetine, agomelatine, desvenlafaxine and bupropion XR
    Plasencia Garcia de Diego, B. O.
    Romero Guillena, S. L.
    Navarro Pablo, R.
    Gotor Sanchez-Luengo, F.
    Santamaria Gomez, O.
    EUROPEAN PSYCHIATRY, 2018, 48 : S205 - S206
  • [34] A history of major depressive disorder and the response to stress
    Ilgen, MA
    Hutchison, KE
    JOURNAL OF AFFECTIVE DISORDERS, 2005, 86 (2-3) : 143 - 150
  • [35] A narrative review of the efficacy of DHA for treatment of major depressive disorder and treatment and prevention of postnatal depression
    Rinaudo, Lyra
    Hopwood, Malcolm
    ADVANCES IN INTEGRATIVE MEDICINE, 2015, 2 (01) : 24 - 30
  • [36] A narrative review of digital biomarkers in the management of major depressive disorder and treatment-resistant forms
    Vignapiano, Annarita
    Monaco, Francesco
    Pagano, Claudio
    Piacente, Martina
    Farina, Federica
    Petrillo, Gianvito
    Sica, Raffaella
    Marenna, Alessandra
    Shin, Jae Il
    Solmi, Marco
    Corrivetti, Giulio
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [37] Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder
    Shusheng Wu
    Yuye Yin
    Longfei Du
    Cellular and Molecular Neurobiology, 2022, 42 : 2571 - 2591
  • [38] Psychotic subtyping of major depressive disorder and posttraumatic stress disorder
    Zimmerman, M
    Mattia, JI
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (05) : 311 - 314
  • [39] Major theories of personality disorder.
    Paris, J
    GENERAL HOSPITAL PSYCHIATRY, 1997, 19 (06) : 448 - 449
  • [40] Adjunctive Brexpiprazole: A Review in Major Depressive Disorder
    McKeage, Kate
    CNS DRUGS, 2016, 30 (02) : 91 - 99